Lymphocyte alterations and elevated complement signalling are key features of refractory myasthenia gravis
Katherine Claire Dodd, Kirsten L. Baillie, James K. L. Holt, Maria Isabel Leite, Lijing Lin A, Peter West, James A. L. Miller, Jennifer E. Spillane, Stuart Viegas, Wioleta Milena Zelek, Jon D. Sussman, Madhvi Menon
This study identifies lymphocyte alterations and elevated complement signaling as key features of refractory myasthenia gravis, with implications for treatment strategies.
bioRxiv · Mar 15, 2025 · PreprintImmunology